United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. (1993). Pricing of drugs codeveloped by federal laboratories and private companies: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, January 25, 1993. U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, First Session, January 25, 1993. Washington, DC: U.S. G.P.O., 1993.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, First Session, January 25, 1993. U.S. G.P.O., 1993.